NAD Supplements in 2026: What Works, What Does Not, and the Prescription Alternative

Medically reviewed by Dr. Jonathan Snipes, MD and Kim Callender, NP, FNP-BC. Last reviewed May 27, 2026.

The short answer

NAD+ supplements work in the sense that NR and NMN raise blood NAD+ measurably in published trials. The rise is modest. The marketing claims about cognitive restoration and longevity sit on a much smaller biochemical effect than the language suggests. Oral NAD+ itself has 2 to 15 percent bioavailability. Precursor supplements (NR, NMN) do better but still convert inefficiently.

Subcutaneous NAD+ injection delivers more than 90 percent of the dose to circulation directly, at similar monthly cost to the premium oral supplements. For patients whose actual goal is to raise cellular NAD+ levels meaningfully, injection is the more direct tool. For patients who want a low-effort daily routine and will not consider needles, NR and NMN supplements are reasonable choices, with the understanding that the effect size is smaller than the marketing implies.

The oral bioavailability problem

NAD+ molecular weight is 663 daltons, large enough that it struggles to cross the gut wall intact. Acid hydrolysis in the stomach and first-pass hepatic metabolism destroy most of an oral NAD+ dose before it reaches systemic circulation. Published estimates for direct oral NAD+ bioavailability range from 2 to 15 percent depending on formulation, with most measurements at the low end.

The supplement industry responded by developing precursor molecules: nicotinamide riboside (NR, sold as Tru Niagen) and nicotinamide mononucleotide (NMN, sold by various brands). Both survive digestion better than NAD+ itself and convert to NAD+ inside the cell. Conversion efficiency is the limiting factor. Each step in the metabolic pathway has its own losses, and the serum NAD+ rise after oral NR or NMN, while real, is smaller than most patients assume from the marketing.

The reference benchmark: subcutaneous NAD+ injection skips the digestive route entirely. The dose deposits in the fat layer beneath the skin and absorbs over 30 to 60 minutes into the bloodstream. Plasma NAD+ rises measurably within the first hour and stays elevated for one to three days. The bioavailability gap between oral and subcutaneous routes is approximately one order of magnitude per matched milligram.

The four main NAD+ supplement categories

The NAD+ supplement market splits into four categories with different mechanisms and different evidence bases.

Nicotinamide riboside (NR): Tru Niagen, Elysium Basis

NR is the most studied of the NAD+ precursor supplements. Tru Niagen and Elysium Basis are the dominant branded products. Both use Niagen, a patented NR formulation manufactured by ChromaDex. Tru Niagen sells the NR alone at standard 300 mg daily doses. Elysium Basis combines NR with pterostilbene, a stilbenoid marketed for its synergistic sirtuin support.

NR is converted to NMN by NRK enzymes and then to NAD+. The two-step conversion is reasonably efficient. Published trials have shown NR supplementation raises whole blood NAD+ by roughly 40 to 60 percent over baseline at the standard 300 mg daily dose. This is the strongest oral evidence base in the category. Both Tru Niagen and Elysium are well-controlled products with third-party testing.

Cost: Tru Niagen retail runs roughly $50 per month for the 300 mg daily dose. Elysium Basis is slightly higher at $60 to $75 per month.

Nicotinamide mononucleotide (NMN)

NMN is one biosynthetic step closer to NAD+ than NR. The intuition is that closer should mean more efficient conversion. The comparative trial data is less complete than the NR base, and when measured head-to-head the difference at typical supplement doses is smaller than the theoretical advantage suggests.

The NMN supplement category is more fragmented than the NR category. Many brands compete on price. Third-party testing quality varies sharply. Heavy metal contamination has been identified in independent tests of some popular NMN brands. The better-controlled NMN products from established supplement brands are reasonable choices; the lowest-cost NMN products are not.

Regulatory status is also less stable. The FDA briefly attempted to reclassify NMN as a drug (rather than a supplement) in late 2022. The reclassification was paused but the supplement-versus- drug question remains open. NR does not face the same regulatory pressure.

Cost: NMN brands range from $25 per month for low-grade products up to $80 per month for premium third-party-tested brands.

Nicotinamide (niacinamide)

Nicotinamide is the simplest NAD+ precursor and the cheapest. It is the molecule that gives B vitamin niacin its name (technically nicotinic acid is niacin; nicotinamide is the form used in most NAD+ pathway supplementation). Nicotinamide raises NAD+ levels at high oral doses but with smaller magnitude than NR or NMN at equivalent gram dosing.

Nicotinamide has the longest clinical track record (decades of use in pellagra prevention and as a vitamin B3 form) and is by far the cheapest of the precursors. The trade-off is the lower relative efficiency at raising NAD+ specifically. Some clinicians recommend nicotinamide for budget-conscious patients who want some NAD+ pathway support without the cost of branded NR or NMN.

Cost: Nicotinamide is available as a generic vitamin at $10 to $20 per month.

Oral NAD+ itself

Some products sell NAD+ directly in oral capsule or sublingual form. The premise is that bypassing the conversion step (NR or NMN to NAD+) should deliver more NAD+ to the cell. The reality is that oral NAD+ has the worst bioavailability of any product in the category, with most of the dose destroyed by stomach acid and hepatic metabolism before reaching circulation.

Sublingual NAD+ products attempt to bypass first-pass metabolism by absorbing through mucous membranes under the tongue. The absorbed fraction is higher than oral but still small compared to injection. These products tend to be priced like premium supplements but deliver less effective dose than NR or NMN.

The honest framing on direct oral NAD+: skip it. NR, NMN, or prescription injection are all better choices.

Side-by-side comparison

When NAD+ supplements still make sense

Despite the bioavailability gap, NAD+ supplements remain a reasonable choice for several patient profiles.

• Hard needle aversion. Patients who will not consider injection under any circumstance. Daily oral NR or NMN delivers some benefit. The magnitude is smaller than injection but is not zero.
• Budget below $50 per month. Generic nicotinamide at $15 per month or NMN at $25 is cheaper than prescription injection. The cost-effective ceiling is lower for supplements; the effective floor is higher.
• Hybrid stack with injection. Some patients use oral NR for daily continuous support plus subcutaneous injection two to three times a week for the deeper pulse. The combination is reasonable under provider supervision.
• Pre-trial of cellular response. Patients uncertain whether they will subjectively notice NAD+ effects sometimes try oral NR for 8 to 12 weeks before committing to the injection protocol. The signal from oral is weaker but present in responders.

When prescription injection is the better tool

• Significant age-related NAD+ decline. Adults over 50 with measurable energy and clarity complaints typically need the larger plasma rise that injection provides. The supplement effect is too small to overcome the deficit in this population.
• Addiction recovery protocols. Clinical addiction recovery loading doses are in the gram-per-day range. Oral supplements cannot replicate this. Injection can.
• Longevity stack initiation. Patients building an anti-aging stack with MOTS-c, Epithalon, or SS-31 typically see better stack synergy with injectable NAD+ than with oral precursors.
• Severe chronic fatigue protocols. Patients with documented mitochondrial dysfunction or post-viral fatigue need the larger cellular NAD+ rise that injection provides.
• Patients who tried supplements and saw no effect. A subset of patients respond to oral NR or NMN minimally. The same patients often respond meaningfully to injection because the dose actually reaches the cell.

How to access prescription NAD+ injection

The path at RxPepsDirect:

1. Add NAD+ Injectable to your protocol from the catalog ($100 per 1000 mg vial, covers approximately 5 weeks at typical maintenance dosing).
2. Pay the $39 medical visit fee at checkout and complete the clinical intake. Disclose any current supplements (Tru Niagen, NMN, etc.) so the prescriber can adjust the protocol.
3. Provider review within 24 hours. Optimal Balance Pharmacy compounds the vial and runs per-batch sterility and endotoxin testing.
4. The vial ships pre-reconstituted via FedEx Overnight in a reusable cooled travel case. Syringes, alcohol swabs, and the prescriber's written dosing protocol are included.

For broader context see how to get NAD+ injections online, what NAD+ actually does, and NAD+ IV vs subcutaneous injection.

Ready to start

For most patients in the second half of life with real interest in NAD+ therapy, prescription injection delivers more cellular NAD+ per dollar than the premium oral supplements. For patients committed to oral, Tru Niagen and Elysium Basis are the established safest choices. The decision is between a smaller effect at slightly lower cost (oral) and a meaningful effect at comparable cost (injection). Browse NAD+ Injectable or browse the longevity category for the complete catalog.